Universal Basic Income and Structural Racism in the US South: HIV Care
University of Arkansas · NCT06186128
Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.
Key facts
- Compensation
- Not posted. Ask the study team before screening.
- Who can join
- Ages 25+ · Men only
- Healthy volunteers
- Accepted
- Study type
- Interventional · Not applicable
- Target enrollment
- 80
- US sites recruiting
- 1
- Study start
- August 3, 2023
- Record last updated
- October 20, 2025
Status re-checked against ClinicalTrials.gov within the last 12 hours.
What the study is about
Universal Basic Income (UBI) is a promising strategy aimed at recalibrating economic systems that are grounded in structural racism. Black men have long been the target of oppressive and interconnected systems of finance and healthcare access, leading to a disproportionate burden of exposure to infectious disease with little healthcare support. Yet to our knowledge, no published UBI studies have ever been implemented exclusively with Black men living with HIV in the US. Motivated and inspired by the innovative health and social science being conducted in extremely resource-limited environments in other parts of the world, we recognize an urgent need to better understand the effect of cash transfers on HIV care among Black men in the US South. The proposed study will be based in Arkansas, which, like other Southern states, has a long history of institutional racism and extremely high rates of racial health disparities, poverty, and chronic disease. We will use a mixed methods research design to conduct an in-depth exploration of a UBI intervention to reduce the racial wage gap and promote the use of culturally relevant protective factors. The provision of a UBI is intended to increase receipt and retention of HIV care services and treatment for Black men through the influx of capital and subsequent increases in culturally-based protective factors such as personal agency and social connections. We hypothesize that providing UBI of $500 per month for 6 months will result in increased HIV care utilization among low-income Black men living with HIV. Secondarily, we hypothesize that the effect of UBI will also increase adherence to HIV medication, such that more UBI recipients will achieve and maintain viral suppression compared to individuals in the control condition.
Being studied: Universal Basic Income
Conditions: HIV; Health Care Utilization
Eligibility criteria
Copied from the official record. The study team makes the final decision at screening.
Show full criteria
Inclusion Criteria
- be at least 25 years old;
- self-report as having received from a medical professional a diagnosis for HIV;
- have an annual income up to 400% of the federal poverty threshold (the 2023 federal poverty threshold is defined as an annual income of less than $14,580 for single adults) in the 12-month period prior to study enrollment;
- be able to understand and speak English and to provide written and verbal informed consent;
- plan to remain in the central Arkansas area for the duration of the study period;
- be willing and able to provide weekly information about all activities related to seeking employment and to share financial and income-related information with the study team;
- self-identify as Black or African American;
- have been assigned the male gender at birth;
- be willing to provide medical releases to allow project staff to access healthcare records, and
- in need of HIV care services (defined as having a detectable viral load meaning >200 copies/mL on most recent viral load test or not having attended a HIV medical care visit in the past 6 months, excluding any visits to the emergency department or rooms or urgent care clinics)
Exclusion Criteria
-
Recruiting US locations
University of Arkansas for Medical Sciences
Little Rock, AR 72204
Site contact: Ashley E Williams, MS · 501-526-4893 · AEWilliams@uams.edu
Study contacts (from the official record)
- Brooke Montgomery, PhD · 501-686-6801 · bemontgomery@uams.edu
- Ashley E Williams, MHS · 501-526-4893 · aewilliams@uams.edu
Similar studies in Arkansas
All healthy volunteers studies in Arkansas →- RecruitingHealthy volunteersPhase 1
Study to Evaluate the Safety, Pharmacokinetic, and Pharmacodynamic Effects of MY006 in Healthy Volunteers and Patients With Peanut Allergy
Mabylon AG
- Location
- Little Rock, AR + 7 other US sites
- Eligibility basics
- Ages 12–55
- RecruitingHealthy volunteersPhase 1
First-in-Human Trial to Assess REGN20423 in Healthy Adult Participants and Adult Participants With Atopic Dermatitis
Regeneron Pharmaceuticals
- Location
- North Little Rock, AR + 5 other US sites
- Eligibility basics
- Ages 18–65
- RecruitingHealthy volunteersPhase 1
A 3-part Study of SYX-5219 in Healthy Volunteers and Participants With Atopic Dermatitis
Sitryx Therapeutics Ltd
- Location
- Arkansas City, AR + 5 other US sites
- Eligibility basics
- Ages 18–65
- RecruitingHealthy volunteers
Extensively Hydrolyzed Formula Growth Monitioring Study (GMS)
Mead Johnson Nutrition
- Location
- Jonesboro, AR + 9 other US sites
- Eligibility basics
- Ages 0 mo–0 mo